UMIN ID: UMIN000001407
Registered date:01/10/2008
The Efficacy and Safety of the new biologic agents (humanized anti-human Interlukin-6 receptor monoclonal antibody) on abnormal lipid metabolism and atherosclerosis for rheumatoid arthritis patients in Japan
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Rheumatoid Arthritis |
Date of first enrollment | 2008/10/01 |
Target sample size | 120 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Adiponectin Remnant like particles-cholesterol Each type of serum cholesterol Carotid echo sonography |
---|---|
Secondary Outcome | DAS28 Remission rate ACR core set Total Sharp Score |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | RA patients who have serious infection patients who have history of severe allergic or anaphylactic reactions to human, humanized or murine monoclonal antibodies patients with Primary or secondary immunodeficiency |
Related Information
Primary Sponsor | The First Department of Internal Medicine.University of Occupation & Environmental Health |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | None |
Secondary ID(s) |
Contact
public contact | |
Name | Kazuyoshi Saito |
Address | 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, JAPAN Japan |
Telephone | 093-603-1611 |
kazu-s@med.uoeh-u.ac.jp | |
Affiliation | University of Occupation & Environmental Health The First Department of Internal Medicine |
scientific contact | |
Name | Yoshiya Tanaka |
Address | 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, JAPAN Japan |
Telephone | 093-603-1611 |
tanaka@med.uoeh-u.ac.jp | |
Affiliation | University of Occupation & Environmental Health The First Department of Internal Medicine |